PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Key Adviser Appointments by Investment Manager

29 Sep 2014 07:00

RNS Number : 7989S
Adamas Finance Asia Limited
29 September 2014
 



Adamas Finance Asia Limited

 

Key Adviser Appointments by Investment Manager

 

 

The Board of Adamas Finance Asia Limited ("ADAM", "Adamas Finance Asia", or the "Company") is pleased to announce that its Hong Kong-based investment manager, Adamas Asset Management (HK) Limited ("Adamas") has announced two senior appointments which will further underpin the Company's strategic repositioning into the credit finance business.

 

Adamas has appointed Viscount Trenchard and Andrew Main as Senior Advisers with immediate effect. Both have extensive experience of Asian investment markets, and one of their key roles will be assisting Adamas in its role as investment manager to ADAM.

 

The two appointments add to Adamas' Asian investment experience as it continues to advise ADAM in reshaping its investment strategy following the reverse takeover in February 2014. The Adamas teams in Asia will play a pivotal role in ADAM's planned transition into a credit finance business that will focus on providing funding for well-managed Chinese growth businesses able to offer secure collateral to support their short-term borrowing requirements.

 

Hugh Trenchard began his career at Kleinwort Benson in 1973 and has more than 40 years' experience in investment banking, including 35 years of involvement with Japan, 12 of them as a resident. He ran Kleinwort Benson's Japanese operations for 11 years, and was Head of Japanese Investment Banking with Robert Fleming & Co Ltd, before working with Mizuho International plc for six years. He served as a Senior Adviser for Japan and Korea to Prudential Financial, Inc. from 2002 to 2008, and is a Vice-Chairman of the British-Japanese Parliamentary Group.

 

He is also currently Chairman of the investment company Stratton Street PCC Limited, whose funds include Renminbi Bond Fund managed by Stratton Street Capital LLP, and a director of several companies including Lotte Chemical UK Limited and the commodity index fund Bache Global Series SICAV. He has been a consultant to Simon Robertson Associates LLP since March 2013.

 

Andrew Main has over 30 years' experience in the securities markets, having worked in London, New York and Tokyo, where he spent most of his career developing a wide range of financial services centred on the Far East. He was an Executive Director with Guinness Mahon, and has worked with Bank of America and Bank Leu. He was the first Managing Partner of Stratton Street Capital LLP until July 2014, and continues to advise the group as a consultant. Mr. Main currently chairs the Next Generation Managers Group of AIMA (Alternate Investment Markets Association), where he is a member of its Standing Committee, and he sits on a number of outside boards in a non-executive capacity on behalf of high net worth families.

 

ADAM Chairman John Croft said: "At this important juncture in the reshaping of Adamas Finance Asia, we are delighted that Adamas has appointed Hugh and Andrew, who together bring tremendous additional depth of Asian experience at a time when the Company is positioned to begin implement its strategic shift into credit finance."

 

 

Enquiries:

Adamas Finance Asia Limited

 

John Croft

+44 (0) 1825 830587

 

 

Nominated Adviser and Joint Broker

 

W H Ireland Limited

 

Tim Feather

Mark Leonard

+44 (0) 113 394 6611

+44 (0) 20 7220 1763

 

 

 

Joint Broker

 

NSBO

Laurie Pinto

 

 

+44 (0) 207 024 4600

 

Public Relations Advisers

 

First City Public Relations (Hong Kong)

 

Allan Piper

+852 2854 2666

 

 

Tavistock Communications (London)

 

Simon Hudson

+44 (0) 20 7920 3170

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDVLFLZKFZBBD
Date   Source Headline
24th Oct 201810:24 amRNSNet Asset Value Update
16th Oct 201810:34 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSInterim Results for Six Months Ended 30 June 2018
17th Aug 201811:43 amRNSResult of AGM
13th Aug 201810:50 amRNSNet Asset Value Update
26th Jul 201812:06 pmRNSNet Asset Value Update
23rd Jul 20189:44 amRNSDisposal of Interest in Global Pharm
11th Jul 201810:38 amRNSResult of General Meeting
28th Jun 20183:50 pmRNSPosting of Annual Report and Accounts
21st Jun 20187:00 amRNSFinal Results for the Year Ended 31 December 2017
21st Jun 20187:00 amRNSAppointment of Broker
15th Jun 20188:36 amRNSDisposal of Interest in Global Pharm & GM Notice
27th Apr 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Apr 20181:57 pmRNSResult of General Meeting
20th Apr 20188:49 amRNSDirector/PDMR Shareholding
5th Apr 20183:54 pmRNSDisposal and Notice of General Meeting
29th Mar 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Mar 20184:44 pmRNSIncreased Ownership in HKMH
19th Mar 20187:00 amRNSNew Investment
8th Feb 201812:17 pmRNSUpdate - Net Asset Value
2nd Feb 20188:24 amRNSDirector/PDMR Shareholding
15th Jan 20187:00 amRNSFurther re. Disposal of Interest in Global Pharm
21st Dec 20178:54 amRNSIncrease in Shareholding in Hong Kong Mining
31st Oct 201710:23 amRNSNet Asset Value Update
2nd Oct 20177:00 amRNSAppointment of Director
22nd Sep 20177:00 amRNSInterim Results For Six Months End 30 June 2017
20th Sep 201711:18 amRNSAGM and Share Consolidation
15th Sep 20177:00 amRNSDisposal of Interest in Global Pharm
30th Aug 20174:50 pmRNSProposed Share Consolidation
4th Aug 20173:36 pmRNSUpdate on Global Pharm Convertible Bond
27th Jul 20177:00 amRNSNet Asset Value(s)
20th Jul 20179:43 amRNSDirectorate Change
20th Jul 20179:27 amRNSAnnual General Meeting
3rd Jul 20179:14 amRNSAppointment of Director
29th Jun 201710:45 amRNSFinal Results
22nd Jun 20178:46 amRNSFurther Payment of Proceeds for TTS Disposal
15th Jun 20179:43 amRNSPayment of Proceeds for TTS Project Disposal
25th May 201711:06 amRNSResult of Meeting
2nd May 20177:00 amRNSChange of Investment Manager and Investing Policy
24th Feb 201711:45 amRNSUPDATE ON TTS PROJECT DISPOSAL
8th Feb 20179:26 amRNSUPDATE ON TTS PROJECT DISPOSAL
31st Jan 20177:00 amRNSDistribution from GCCF
23rd Jan 20179:15 amRNSUPDATE: REDEMPTION OF GLOBAL PHARM CONVERTIBLE
13th Jan 20178:15 amRNSUPDATE ON TTS PROJECT DISPOSAL
4th Jan 20179:00 amRNSProposed Disposal
29th Dec 20167:00 amRNSDirector/PDMR Shareholding
22nd Dec 20161:18 pmRNSDirector/PDMR Shareholding
20th Dec 20164:19 pmRNSDirector/PDMR Shareholding
13th Dec 20169:23 amRNSDirector/PDMR Shareholding
6th Dec 201612:34 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.